Pharmacology of Immunological Agents

Immunological agents are a broad class of drugs that modify the immune system’s activity, either by enhancing or suppressing its function. They are like tools that help your immune system work better or differently. For example, vaccines help your body fight off specific diseases (enhancing) or autoimmune drugs treat autoimmune diseases, where the immune system attacks the body’s own tissues (suppressing).

Types of Immunological Agents:

Immunostimulants: These are drugs that boost the immune system’s function, often used when the immune system is weakened or underperforming.
Immunosuppressants: These drugs reduce or suppress the immune system’s activity, essential in preventing transplant rejection and treating autoimmune diseases.

I. Immunostimulants (Immune Stimulants)

They are also known as Immunomodulators or Immunostimulators. They are substances that stimulate the immune system and increase the ability of the immune system to fight against disease and infection.

Uses of Immunostimulants:

Infections (Viral, Bacterial, Fungal)
Cancers (Melanoma, Leukemias, Renal Cell Carcinoma)
Immunodeficiency (e.g., AIDS, congenital disorders)
To prevent infections (Prophylaxis)

Types of Immunostimulants

Specific Immunostimulants	Non-Specific Immunostimulants
Provide Antigen-specific immunity. They act as antigens and stimulate specific antibody production.	They act against antigens or enhance the immune response by acting primarily on T lymphocytes and macrophages.
Example: Vaccines	Examples: Immunoglobulins, Thalidomide, Interferons/Cytokines, Interleukins, Immunocyanin.

1. Vaccines (Specific Immunostimulants)

A vaccine is a biological preparation that improves immunity to a particular disease.
Vaccines contain certain agents which stimulate the immune system to recognize foreign agents.
They are suspensions of dead microorganisms (inactivated), attenuated (live but weakened), or toxins of microorganisms (toxoids).
Example: BCG vaccine for tuberculosis.

2. Immunoglobulins

They are human gamma globulins or antibodies that function like natural immunoglobulins to provide immediate, passive immunity.
Examples: Tetanus Ig, Antidiphtheria Ig, Hepatitis Ig, Rabies Ig.

3. Thalidomide

These are drugs that enhance cell-mediated immunity by acting on T lymphocytes.
Uses: Multiple myeloma, Erythema Nodosum Leprosum, and Lupus erythematosus.
Warning: They are highly teratogenic drugs (causing severe fetal limb deformities like phocomelia) so they MUST be strictly avoided in pregnancy.

4. Interferons

Interferons are cytokines. They are natural proteins produced naturally by cells (such as T helper or CD4 cells) in response to viral infections and other stimuli. They help the body's immune system fight infection and other diseases, such as cancer.

Therapeutic Action: They prevent viral particles from replicating inside host cells. They stimulate cells to produce antiviral proteins and enhance the cytotoxicity of T-cells and natural killer (NK) cells. They inhibit tumor growth by enhancing the host’s immune response and increasing antigen presentation to lymphocytes.
Pharmacokinetics: Well absorbed via subcutaneous (SC) or intramuscular (IM) injection, reaching peak plasma levels within 3-8 hours. Metabolized in the liver and kidneys and excreted primarily through the kidneys.
Contraindications: Allergies to interferons, pregnancy and lactation (due to teratogenic effects), cardiac diseases (particularly arrhythmias and hypertension), and severe myelosuppression.
Uses: Melanoma, Kaposi sarcoma, leukemia, lymphomas, and severe viral infections (Hepatitis B & C).

Drug	Indications	Therapeutic Action & Notes	Adverse Effects
Interferon alfa-2b	Chronic hepatitis C, Kaposi’s sarcoma, malignant melanoma	Inhibits viral replication, enhances immune response, and increases macrophage activity.	Flu-like symptoms, myelosuppression, depression, suicidal ideation.
Interferon alfacon-1	Hepatitis C	Inhibits viral replication and boosts immune system.	Headache, dizziness, bone marrow suppression, photosensitivity.
Interferon alfa-n3	Genital warts (intralesional), basal cell carcinoma	Inhibits viral replication and tumor growth.	Fatigue, anorexia, nausea, vomiting.
Interferon beta-1a	Multiple sclerosis (MS)	Reduces the frequency of clinical exacerbations and slows the progression of disability in MS by modulating inflammation.	Injection site reactions, flu-like symptoms, liver dysfunction.
Interferon beta-1b	Multiple sclerosis	Similar to Interferon beta-1a; modulates the immune system to reduce inflammation in the CNS.	Fatigue, depression, flu-like symptoms, liver impairment.
Interferon gamma-1b	Chronic granulomatous disease, severe osteopetrosis	Enhances the respiratory burst of macrophages, stimulating greater antimicrobial activity and phagocytosis.	Fever, rash, diarrhea, myalgia.
Peginterferon alfa-2a	Chronic hepatitis C and B	Pegylated (attached to polyethylene glycol) to increase half-life. Increases immune response against hepatitis viruses.	Neutropenia, thrombocytopenia, liver enzyme abnormalities, flu-like symptoms.
Peginterferon alfa-2b	Chronic hepatitis C	Longer-lasting effects due to its pegylated form, allowing less frequent dosing (usually once weekly).	Similar to Peginterferon alfa-2a, including severe hematologic toxicity and major depression.

5. Interleukins

Interleukins are cytokines that play an essential role in the immune response by promoting the proliferation of lymphocytes and other immune cells. Think of the immune system as a big army; Interleukins are like the signals that tell different parts of the army what to do.

Activate immune cells: Tell certain cells to start fighting off invaders.
Control inflammation: Help regulate how much inflammation happens in response to an infection or injury.
Promote cell growth: Help immune cells multiply and become stronger.
Pharmacokinetics: Absorbed via SC or IV injection, peak levels within hours. Metabolized in the kidneys and excreted in urine.
Contraindications: Allergies to interleukins or E. coli-produced products. Pregnancy, lactation, and patients with severe renal, liver, or cardiovascular impairments.

Drug	Indications	Therapeutic Action & Notes	Adverse Effects
Aldesleukin (IL-2)	Metastatic renal cell carcinoma, metastatic melanoma	Stimulates the proliferation of T-cells and natural killer (NK) cells, enhances the immune response against cancer.	Capillary leak syndrome (fluid shifts into extravascular space), hypotension, anemia, severe fluid retention.
Oprelvekin (IL-11)	Prevention of severe thrombocytopenia in chemotherapy	Increases platelet production by directly stimulating megakaryocyte production in the bone marrow.	Fluid retention, peripheral edema, dyspnea, cardiac arrhythmias (atrial fibrillation).

General Side-Effects of Immunostimulants:

Administration of immunostimulants often mimics a viral infection because these are the very chemicals the body releases during an illness.

Nausea, chills, profound fatigue.
Headache, back pain, and joint pain (myalgia/arthralgia).
Fever and vomiting.
Constipation.

II. Immunosuppressants (Immune Suppressants)

Immunosuppressants are drugs that inhibit immunity. They suppress cell-mediated immune responses, antibody-mediated immune responses, or both.

These are like the “peacekeepers” of the immune system. They dampen down the immune response, preventing it from overreacting. They are mainly used to prevent transplant/graft rejection and to treat autoimmune diseases.

General Uses & Indications:

Organ transplant (Prevention of rejection)
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis
Systemic Lupus Erythematosus (SLE)
Multiple sclerosis (MS)
Psoriasis or psoriatic arthritis
Rheumatoid arthritis (RA)

Classification of Immunosuppressants

T-Cell Inhibitors: cyclosporine, tacrolimus, sirolimus.
Cytotoxic drugs (T- and B-Cell Suppressors): Methotrexate, Azathioprine, Cyclophosphamide, Chlorambucil, Abatacept, Alefacept.
Corticosteroids: Methylprednisone, Hydrocortisone.
Interleukin-Receptor Antagonists: Anakinra.
Immunosuppressant Antibodies (Monoclonal Antibodies): Muromonab-CD3, Infliximab, Adalimumab, Alemtuzumab, etc.

1. T-Cell Inhibitors (Calcineurin Inhibitors & mTOR Inhibitors)

These drugs specifically disrupt T-cell activation and proliferation, which are the primary cells responsible for cellular rejection of transplanted organs. Cyclosporine is the most commonly used immunosuppressant for this purpose.

Cyclosporine: Inhibits calcineurin, preventing the production of IL-2. Side effects include profound nephrotoxicity, hypertension, hirsutism, and gingival hyperplasia.
Tacrolimus: A macrolide that also inhibits calcineurin. More potent than cyclosporine. Associated with nephrotoxicity and neurotoxicity.
Sirolimus (Rapamycin): An mTOR inhibitor that prevents T-cell response to IL-2. Often used in renal transplants to avoid calcineurin-induced nephrotoxicity.

2. T- and B-Cell Suppressors (Cytotoxic Drugs)

These drugs inhibit the proliferation and activity of T-cells and B-cells. They are generally well absorbed (PO or IV), metabolized in the liver, and excreted via the kidneys. Contraindicated in pregnancy, lactation, renal/hepatic impairment, active infections, or known neoplasms.

Drug	Indications	Therapeutic Action & Notes	Adverse Effects
Azathioprine	Prevention of kidney transplant rejection, severe rheumatoid arthritis.	A cytotoxic antimetabolite that inhibits purine synthesis, directly reducing T and B-cell DNA synthesis and proliferation.	Severe bone marrow suppression, hepatotoxicity, profound nausea, increased risk of neoplasms.
Abatacept	Rheumatoid arthritis, juvenile idiopathic arthritis.	Inhibits T-cell activation by binding to CD80 and CD86 receptors on antigen-presenting cells (blocking the required co-stimulatory signal).	Headache, upper respiratory infections, hypertension, nausea.
Alefacept	Plaque psoriasis.	Inhibits T-cell activation and physically reduces T-cell numbers.	Lymphopenia, hepatotoxicity, opportunistic infections.
Methotrexate / Cyclophosphamide	Severe autoimmune diseases (RA, Lupus), Cancers.	Cytotoxic agents that interfere with cellular DNA synthesis, leading to death of rapidly dividing immune cells.	Myelosuppression, hemorrhagic cystitis (Cyclophosphamide), pulmonary fibrosis, hepatotoxicity.

3. Corticosteroids

Examples: Methylprednisolone, Hydrocortisone, Prednisone.
Action: Potent anti-inflammatory agents that suppress the entire inflammatory cascade, reduce cytokine production, and cause lymphocyte apoptosis. Used heavily in acute transplant rejection episodes and severe autoimmune flares.

4. Interleukin-Receptor Antagonists

This class of drugs blocks interleukin activity, which is critical in the inflammatory and immune response.

Drug	Indications	Therapeutic Action & Notes	Adverse Effects
Anakinra	Moderate to severe Rheumatoid arthritis (when one or more DMARDs have failed).	Competitively blocks the interleukin-1 (IL-1) receptor, reducing inflammation and halting joint cartilage degradation/damage.	Headache, sinusitis, nausea, severe infections, injection-site reactions.

5. Monoclonal Antibodies (Immunosuppressant Antibodies)

Monoclonal antibodies are laboratory-produced molecules that can mimic the immune system’s ability to fight off harmful pathogens or selectively suppress specific pathways. These are like highly specific “guided missiles” or a "sniper team" designed to target and attack specific cells or molecules, leaving the rest of the immune army alone.

Pharmacokinetics: Administered via IV injection/infusion and have variable half-lives depending on the specific antibody. Metabolized and excreted through the reticuloendothelial system.
Contraindications: Known allergy to murine (mouse) products. Contraindicated in fluid overload. Should be used cautiously with fever (treat the fever before beginning therapy). Avoid in pregnancy/lactation unless the benefit clearly outweighs fetal risk.

Drug	Indications / Uses	Therapeutic Action & Notes	Adverse Effects
Adalimumab (Humira)	Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's.	Binds to tumor necrosis factor (TNF) alpha, inhibiting its severe inflammatory cascade effects.	Infections (Reactivation of TB), malignancies, injection site reactions.
Alemtuzumab (Campath)	Chronic lymphocytic leukemia (CLL), Multiple Sclerosis.	Targets the CD52 antigen on mature lymphocytes, leading to antibody-dependent cellular cytolysis.	Severe infusion reactions, profound immunosuppression/cytopenias, opportunistic infections.
Basiliximab (Simulect) / Daclizumab	Prevention of kidney transplant rejection.	Blocks the interleukin-2 (IL-2) receptor (CD25) on activated T-cells, preventing their proliferation.	GI disturbances, severe infections, hypersensitivity/anaphylaxis.
Bevacizumab (Avastin)	Metastatic colorectal cancer, glioblastoma, non-small cell lung cancer.	Binds to Vascular Endothelial Growth Factor (VEGF), inhibiting tumor angiogenesis (blood vessel growth).	Hemorrhage, GI perforations, impaired wound healing, hypertension.
Certolizumab (Cimzia) / Infliximab	Crohn's disease, Rheumatoid arthritis.	TNF-alpha blockers; reduction of the signs and symptoms of severe inflammatory diseases.	Serious infections, heart failure exacerbation, lupus-like syndrome.
Cetuximab (Erbitux)	Head, neck, and colorectal cancers.	Epidermal Growth Factor Receptor (EGFR) inhibitor.	Severe skin rash, infusion reactions, hypomagnesemia.
Rituximab (Rituxan)	B-cell non-Hodgkin lymphoma, severe RA.	Targets CD20 antigen on B-cells, causing B-cell lysis.	Fatal infusion reactions, tumor lysis syndrome, severe mucocutaneous reactions.

Other Specific Indications for Monoclonal Antibodies:

Treatment of paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis (e.g., Eculizumab).
Treatment of asthma with a very strong allergic component and seasonal allergic rhinitis not controlled by common medicine (e.g., Omalizumab targeting IgE).
Prevention of serious RSV (Respiratory syncytial virus) infection in high-risk premature children (e.g., Palivizumab).
Treatment of metastatic breast cancer overexpressing HER2 (e.g., Trastuzumab).
Treatment of severe psoriasis.

General Side-Effects of Immunosuppressants & Monoclonal Antibodies:

The most serious adverse effect associated with the use of monoclonal antibodies is acute pulmonary edema (dyspnea, chest pain, wheezing), which is associated with severe fluid retention and capillary leak.

Infections (Due to suppressed immune system):
- Blood infections like sepsis.
- Fungal infections like oral thrush and skin fungus.
- Skin infections like cellulitis.
- Respiratory infections, including severe colds, flu, and pneumonia.
Systemic / General: Fever, chills, profound malaise, myalgia. Headaches, trouble concentrating or remembering.
Gastrointestinal: Nausea, diarrhea, vomiting, stomach upset, mouth sores.
Hematologic: Intravascular hemolysis with resultant fatigue, pain, dark urine, shortness of breath, and blood clots.
Corticosteroid-specific effects: Acne, diabetes (hyperglycemia), rapid weight gain, thinning bones (osteoporosis), fatigue, hair loss or abnormal hair growth, high blood pressure.

NURSING CARE PLAN & MANAGEMENT

No.	Nursing Diagnosis	Interventions & Rationale
1	Risk for Infection related to profound immunosuppression secondary to T/B cell inhibitors, monoclonal antibodies, or corticosteroids.	Implement strict neutropenic precautions: Ensure scrupulous hand hygiene. Restrict visitors with active respiratory or systemic infections. Avoid fresh flowers/plants in the room. Monitor vital signs closely: A low-grade fever may be the only sign of a life-threatening systemic infection in an immunosuppressed patient. Educate the patient on hygiene: Teach proper oral care to prevent thrush, meticulous skin care to prevent cellulitis, and avoidance of large crowds.
2	Acute Pain & Impaired Comfort related to "flu-like syndrome" (myalgia, arthralgia, fever, chills) secondary to Interferon or Interleukin therapy.	Administer pre-medications as ordered: Give Acetaminophen (paracetamol) or antihistamines before injecting interferons to blunt the severe flu-like response. Encourage rest and fluid intake: Promotes comfort and clears metabolic waste products. Monitor injection sites: Rotate sites for SC injections to prevent tissue necrosis and localized severe injection-site reactions.
3	Risk for Impaired Gas Exchange / Fluid Volume Excess related to capillary leak syndrome (Aldesleukin) or acute pulmonary edema (Monoclonal antibodies).	Assess respiratory status constantly: Auscultate lungs for crackles/wheezes. Monitor for dyspnea, chest pain, and declining oxygen saturation. Monitor Daily Weights and strict I&O: Extreme fluid retention is a critical adverse effect; sudden weight gain indicates fluid shifting to extravascular spaces. Be prepared for emergency intervention: Have oxygen and emergency resuscitation equipment readily available during initial monoclonal antibody infusions (due to risk of anaphylaxis and pulmonary edema).
4	Deficient Knowledge regarding long-term therapy, strict dosing schedules, and teratogenic risks (e.g., Thalidomide, Methotrexate).	Educate on strict contraception: Patients taking teratogenic drugs (like Thalidomide) MUST use two forms of birth control and undergo routine pregnancy testing. Teach self-administration techniques: If the patient is discharged with SC injections (e.g., Anakinra, Adalimumab), ensure they demonstrate proper aseptic technique and site rotation.

V. References

Karch, A. M. (2019). Focus on Nursing Pharmacology (8th ed.). Wolters Kluwer.
Burchum, J. R., & Rosenthal, L. D. (2021). Lehne's Pharmacology for Nursing Care (11th ed.). Elsevier.
World Health Organization (WHO) Guidelines on Immunizations and Biological Preparations.
Provided Presentation Slides and Lecture Notes on Immunostimulants and Immunosuppressants.